Pharmaceutical Executive
June 06, 2006
0
0
Small molecules are an increasingly viable option for cancer therapeutics
June 06, 2006
0
0
Increased demand for plant-based hormones has spurred Wyeth to ask FDA to set marketing limits on compounded therapies
June 06, 2006
0
0
Medicare Part D has increased drug sales and payers are still trying to hold down costs.